About our Company: Regado Biosciences, Inc. is a growing biopharmaceutical company with an exciting future! We are pioneering the development of active-controlled aptamer-based antithrombotics for use in acute care cardiovascular interventional procedures. Our lead product candidate, REG1, consists of a potent, specific Factor IX inhibitor (pegnivacogin) and its matched active control agent, anivamersen. We are about to begin a large, international phase 3 trial of REG1 in PCI (Percutaneous coronary intervention) and are expanding our staff in support of this trial. Additionally, we have a pipeline of products in earlier stages of development.
Regado maintains facilities and staff in both Basking Ridge, NJ and Durham, NC.
We have the following open positions:
If interested, please email your resume and salary requirements to firstname.lastname@example.org